Rocket Pharmaceuticals Inc

2026. g. 21. aug. 19:51 UTC

Rocket Pharmaceuticals Inc is rising during Friday's session, supported by strength in the biotechnology sector. The stock remains above its 20-day moving average.

2026. g. 20. aug. 20:06 UTC

Rocket Pharmaceuticals Inc is lower today, reflecting broader pressures in the biotechnology sector. The overall market is also trending downwards.

2026. g. 19. aug. 20:02 UTC

Rocket Pharmaceuticals Inc shares are sharply higher today, reflecting strong momentum amid notable gains in biotechnology stocks and positive sector dynamics.

2026. g. 18. aug. 19:46 UTC

Rocket Pharmaceuticals shares are lower today, reflecting a decline since Monday. Broader market trends and rising Treasury yields may be influencing investor sentiment.

2026. g. 17. aug. 23:46 UTC

Rocket Pharmaceuticals Inc shares are higher in after-market trading, reflecting positive performance despite broader market pressures and no specific company news identified.

2026. g. 14. aug. 22:01 UTC

Rocket Pharmaceuticals Inc is trading lower in after-market hours, with no specific news identified. Broader market concerns may be influencing the decline.

2026. g. 13. aug. 19:56 UTC

Rocket Pharmaceuticals Inc shares are lower today, continuing a recent downward trend amid rising U.S. unemployment claims, with no specific company news identified.

2026. g. 12. aug. 19:16 UTC

Rocket Pharmaceuticals Inc shares are lower today, with no specific news driving the decline. Earlier, the stock reached a session high before falling.

2026. g. 11. aug. 20:02 UTC

Rocket Pharmaceuticals shares are lower after Wedbush cut its price target to $15, reflecting concerns over mixed second-quarter earnings results.

2026. g. 10. aug. 23:26 UTC

Rocket Pharmaceuticals reported Q2 net income of $123.2 million, with EPS of $1.08, significantly exceeding estimates. Shares traded higher in after-market hours.

2026. g. 8. aug. 00:01 UTC

Rocket Pharmaceuticals Inc. shares are higher in after-market trading, advancing modestly since Friday's close and remaining above its 20-day moving average.

2026. g. 7. aug. 23:01 UTC

Rocket Pharmaceuticals Inc. shares have shown little change in after-market trading, remaining within a narrow band since Friday's close.

2026. g. 6. aug. 23:06 UTC

Rocket Pharmaceuticals Inc is trading higher in after-market hours, remaining above its 20-day moving average amid no specific news to explain the movement.

2026. g. 5. aug. 20:02 UTC

Rocket Pharmaceuticals is rising Wednesday, driven by a strong Biotechnology sub-sector. The stock remains above its 20-day moving average during the session.

2026. g. 4. aug. 19:26 UTC

Rocket Pharmaceuticals shares rise as Wedbush maintains Outperform rating with a $16 price target. The company also reported promising safety results in its Phase 2 trial.

2026. g. 3. aug. 22:01 UTC

Rocket Pharmaceuticals shares are lower in after-market trading despite a positive clinical safety update on its Phase 2 trial for RP-A501.

2026. g. 31. jūl. 22:01 UTC

Rocket Pharmaceuticals shares declined in after-hours trading, continuing a downward trend since Friday's close. The stock remains below its 20-day moving average.

2026. g. 30. jūl. 21:51 UTC

Rocket Pharmaceuticals is lower in after-market hours, reflecting declines in the Biotechnology sub-sector. The stock remains below its 20-day moving average.

2026. g. 29. jūl. 20:52 UTC

Rocket Pharmaceuticals shares are lower in after-market hours amid a broader market decline driven by rising crude oil prices and geopolitical tensions.

2026. g. 28. jūl. 19:22 UTC

Rocket Pharmaceuticals Inc is trading lower today, reflecting broader market trends. The stock remains below its 20-day moving average and near its one-month trading range low.

2026. g. 27. jūl. 16:16 UTC

Rocket Pharmaceuticals is trading higher today, recovering from an earlier dip. Broader market volatility follows a notable decline in oil prices amid geopolitical developments.

2026. g. 24. jūl. 19:06 UTC

Rocket Pharmaceuticals is trading lower, extending a five-session decline. Broader market pressures and falling crude oil prices are influencing investor sentiment.

2026. g. 22. jūl. 20:06 UTC

Rocket Pharmaceuticals shares are lower, marking four consecutive sessions of declines. The stock has closed below its 20-day moving average.

2026. g. 20. jūl. 19:46 UTC

Rocket Pharmaceuticals shares are higher today amid mixed analyst sentiments, with Wall Street Zen downgrading to "sell" and Chardan Capital maintaining a "buy" rating.